Document Type : Original Article

Authors

1 Department of Epidemiology, School of Health, Mashhad University of Medical Sciences, Mashhad, Iran

2 Department of Epidemiology, School of Health, Social Determinants of Health Research Center, Mashhad University of Medical Sciences, Mashhad, Iran

10.30476/jhsss.2024.104139.1979

Abstract

Background: Hypertension and diabetes mellitus are major risk factors for cardiovascular diseases, the leading cause of premature death worldwide. In Iran, screening programs for these conditions have been integrated into the health system, but a comprehensive evaluation is lacking. This study aimed to analyze the results of the national diabetes and hypertension screening survey in Iran, with a focus on the Mashhad metropolis.
Methods: We conducted a cross-sectional, descriptiveanalytical study using data from the 2023 National Diabetes and Hypertension Screening Program in Iran. The study population included 2,445,151 individuals aged 18 and above. Demographic information, medical history, and screening results were collected. Univariate and multivariate logistic regression analyses were performed to determine the factors associated with hypertension and diabetes.
Results: Of the participants, 8.15% had previously known hypertension, and 1.35% were newly identified as suspected hypertensive people. For diabetes, 3.36% had a previous diagnosis, and 0.72% were newly identified as suspected diabetics. Age was the strongest predictor for both conditions (AOR for 61+ age group: 79.34, 95% CI: 73.06-86.16 for both conditions). BMI over 25 was also a significant risk factor (AOR: 2.31, 95% CI: 2.23- 2.40 for suspected hypertension and diabetes). Higher education levels showed a protective effect against both conditions.
Conclusion: This large-scale screening program revealed substantial rates of undiagnosed hypertension and diabetes in Iran. The study highlights the complex interplay of demographic, socioeconomic, and lifestyle factors in the development of these conditions. These findings underscore the importance of targeted screening and prevention strategies, particularly focusing on older adults, those with higher BMI, and populations with lower educational attainment.

Highlights

Khadijeh Ghasemi (Google Scholar)

Ehsan Mosafarkhani (Google Scholar)

Keywords

  1. World Health Organization (WHO). Cardiovascular disease. Available at: http://www.who int/cardiovascular_diseases/en/. 2017.
  2. Al-Makki A, DiPette D, Whelton PK, Murad MH, Mustafa RA, Acharya S, et al. Hypertension Pharmacological Treatment in Adults: A World Health Organization Guideline Executive Summary. Hypertension. 2022;79(1):293-301. doi: 10.1161/HYPERTENSIONAHA.121.18192. PubMed PMID: 34775787; PubMed Central PMCID: PMC8654104.
  3. Li G, Fan Z, Zhou Y, Chen Y, Shi X, Xie X, et al. The contributions of risk factors on health adjusted life expectancy (HALE) changes from 1990 to 2017: a serial cross-sectional analysis from the GBD study. Global Transitions. 2022;4:90-9. doi:1016/j.glt.2022.12.002.
  4. Dokunmu TM, Yakubu OF, Adebayo AH, Olasehinde GI, Chinedu SN. Cardiovascular Risk Factors in a Suburban Community in Nigeria. Int J Hypertens. 2018; 2018:6898527. doi: 10.1155/2018/6898527. PubMed PMID: 29805795; PubMed Central PMCID: PMC5899850.
  5. Mills KT, Bundy JD, Kelly TN, Reed JE, Kearney PM, Reynolds K, et al. Global Disparities of Hypertension Prevalence and Control: A Systematic Analysis of Population-Based Studies From 90 Countries. Circulation. 2016;134(6):441-50. doi: 10.1161/CIRCULATIONAHA.115.018912. PubMed PMID: 27502908; PubMed Central PMCID: PMC4979614.
  6. Zhou D, Xi B, Zhao M, Wang L, Veeranki SP. Uncontrolled hypertension increases risk of all-cause and cardiovascular disease mortality in US adults: the NHANES III Linked Mortality Study. Sci Rep. 2018;8(1):9418. doi: 10.1038/s41598-018-27377-2. PubMed PMID: 29925884; PubMed Central PMCID: PMC6010458.
  7. World Health Organization (WHO). Classification of diabetes mellitus. 2019.
  8. Atlas D. International diabetes federation. IDF Diabetes Atlas, 7th edn Brussels, Belgium: International Diabetes Federation. 2015;33(2).
  9. Deshpande AD, Harris-Hayes M, Schootman M. Epidemiology of diabetes and diabetes-related complications. Phys Ther. 2008;88(11):1254-64. doi: 10.2522/ptj.20080020. PubMed PMID: 18801858; PubMed Central PMCID: PMC3870323.
  10. Menke A, Casagrande S, Geiss L, Cowie CC. Prevalence of and Trends in Diabetes Among Adults in the United States, 1988-2012. JAMA. 2015;314(10):1021-9. doi: 10.1001/jama.2015.10029. PubMed PMID: 26348752.
  11. Akselrod S, Collins TE, Berlina D, De Pinho Campos K, Fones G, de Sousa Neves D, et al. Multisectoral action to address noncommunicable diseases: lessons from three country case studies. Front Public Health. 2024;12:1303786. doi: 10.3389/fpubh.2024.1303786. PubMed PMID: 38450149; PubMed Central PMCID: PMC10915276.
  12. Kearney PM, Whelton M, Reynolds K, Muntner P, Whelton PK, He J. Global burden of hypertension: analysis of worldwide data. Lancet. 2005;365(9455):217-23. doi: 10.1016/S0140-6736(05)17741-1. PubMed PMID: 15652604.
  13. American Diabetes Association; Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 2010; 33 (Supplement_1): S62–S69. doi: 10.2337/dc10-S062.
  14. Centers for Disease Control and Prevention (CDC). Vital signs: awareness and treatment of uncontrolled hypertension among adults--United States, 2003-2010. MMWR Morb Mortal Wkly Rep. 2012;61:703-9. PubMed PMID: 22951452.
  15. Sowers JR, Epstein M, Frohlich ED. Diabetes, hypertension, and cardiovascular disease: an update. Hypertension. 2001;37(4):1053-9. doi: 10.1161/01.hyp.37.4.1053. Erratum in: Hypertension 2001;37(5):1350. PubMed PMID: 11304502.
  16. Herman WH, Zimmet P. Type 2 diabetes: an epidemic requiring global attention and urgent action. Diabetes Care. 2012;35(5):943-4. doi: 10.2337/dc12-0298. PubMed PMID: 22517937; PubMed Central PMCID: PMC3329834.
  17. Knowler WC, Barrett-Connor E, Fowler SE, Hamman RF, Lachin JM, Walker EA, et al. Diabetes Prevention Program Research Group. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med. 2002;346(6):393-403. doi: 10.1056/NEJMoa012512. PubMed PMID: 11832527; PubMed Central PMCID: PMC1370926.
  18. Herman WH, Ye W, Griffin SJ, Simmons RK, Davies MJ, Khunti K, et al. Early Detection and Treatment of Type 2 Diabetes Reduce Cardiovascular Morbidity and Mortality: A Simulation of the Results of the Anglo-Danish-Dutch Study of Intensive Treatment in People With Screen-Detected Diabetes in Primary Care (ADDITION-Europe). Diabetes Care. 2015;38(8):1449-55. doi: 10.2337/dc14-2459. PubMed PMID: 25986661; PubMed Central PMCID: PMC4512138.
  19. Norouzi M, Amiri Z, Mosa Farkhani E, Hoseini SJ, Khosravi Asl T. Advancing Healthcare Infrastructure: The Features of Iran’s Sina Electronic Health Record System. Epidemiology. 2024;11(2). doi: 34172/ehsj.26105.
  20. World Health Organization (WHO). Diabetes. 2021. Available at: https://www.who.int/news-room/fact-sheets/detail/diabetes.
  21. Mills KT, Stefanescu A, He J. The global epidemiology of hypertension. Nat Rev Nephrol. 2020;16(4):223-237. doi: 10.1038/s41581-019-0244-2. PubMed PMID: 32024986; PubMed Central PMCID: PMC7998524.
  22. Zhou B, Perel P, Mensah GA, Ezzati M. Global epidemiology, health burden and effective interventions for elevated blood pressure and hypertension. Nat Rev Cardiol. 2021;18(11):785-802. doi: 10.1038/s41569-021-00559-8. PubMed PMID: 34050340; PubMed Central PMCID: PMC8162166.
  23. Sun H, Saeedi P, Karuranga S, Pinkepank M, Ogurtsova K, Duncan BB, et al. IDF Diabetes Atlas: Global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045. Diabetes Res Clin Pract. 2022;183:109119. doi: 10.1016/j.diabres.2021.109119.
  24. Legato MJ, Johnson PA, Manson JE. Consideration of Sex Differences in Medicine to Improve Health Care and Patient Outcomes. JAMA. 2016;316(18):1865-1866. doi: 10.1001/jama.2016.13995. PubMed PMID: 27802499.
  25. Cutler DM, Lleras-Muney A. Understanding differences in health behaviors by education. J Health Econ. 2010;29(1):1-28. doi: 10.1016/j.jhealeco.2009.10.003. PubMed PMID: 19963292; PubMed Central PMCID: PMC2824018.
  26. Guh DP, Zhang W, Bansback N, Amarsi Z, Birmingham CL, Anis AH. The incidence of co-morbidities related to obesity and overweight: a systematic review and meta-analysis. BMC Public Health. 2009;9:88. doi: 10.1186/1471-2458-9-88. PubMed PMID: 19320986; PubMed Central PMCID: PMC2667420.
  27. S. Department of Health and Human Services. The Health Consequences of Smoking—50 Years of Progress: A Report of the Surgeon General. Atlanta: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health. 2014.